Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patients

Clinical Biochemistry

Volumn 32, Issue 5, 1999, Pages 339-346

  Bairaktari, Eleni ^a   Elisaf, Moses ^a   Katsaraki, Afroditi ^a   Tsimihodimos, Vasilios ^a   Tselepis, Alexandros D ^b   Siamopoulos, Kostas C ^a   Tsolas, Orestes ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

HDL C; Hemodialysis patients; Method comparison; Quantification; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; TRIACYLGLYCEROL;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; BIOASSAY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRECIPITATION; PRIORITY JOURNAL; SERUM; ULTRACENTRIFUGATION;

ADULT; CHOLESTEROL, HDL; CLINICAL CHEMISTRY TESTS; DEXTRAN SULFATE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MAGNESIUM; MALE; MIDDLE AGED; PRECIPITATION; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0032852148     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00031-4     Document Type: Article

References (22)

1. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med. 62:1977;707-714.
2. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:1989;8-15.
3. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA. 269:1993;3015-3023.
4. Sugiuchi H., Uji Y., Okabe H., et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem. 41:1995;717-723.
5. Nauck M., März W., Haas B., Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem. 42:1996;424-429.
6. 2+ method. Clin Chem. 43:1997;816-823.
7. Huang Y.C., Kao J.T., Tsai K.S. Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol. Clin Chem. 43:1997;1048-1055.
8. Nauck M., März W., Jarausch J., et al. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Clin Chem. 43:1997;1622-1629.
9. Reed R.G. In search of the ideal measure of high-density lipoprotein [Editorial]. Clin Chem. 43:1997;1809-1810.
10. Cobbaert C., Zwang L., Ceriotti F., et al. Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay. Clin Chem. 44:1998;779-789.
11. Simo J.M., Castellano I., Ferre N., Joven J., Camps J. Evaluation of a homogeneous assay for high-density lipoprotein cholesterol limitations in patients with cardiovascular, renal, and hepatic disorders . Clin Chem. 44:1998;1233-1241.
12. Nauck M., Marz W., Wieland H. New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol. Clin Chem. 44:1998;1443-1451.
13. Rifai N., Cole T.G., Iannotti E., et al. Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay. Clin Chem. 44:1998;1452-1458.
14. Samuelsson O., Attmam P.-O., Knight-Gibson C., et al. Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant. 9:1994;1580-1585.
15. Shoji T., Nishizawa Y., Kawagishi T., et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis. 131:1997;229-236.
16. Elisaf M.S., Bairaktari H.T., Tzallas C.S., Germanos N.K., Siamopoulos K.C. Atherogenic lipid and lipoprotein parameters in hemodialysis patients. Dialysis Transplant. 24:1995;642-650.
17. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388.
18. Carey RN, Garber CC. Evaluation of methods. In: Kaplan LA, Pesce AJ, Eds. Clinical chemistry: theory, analysis and calculation. Princeton, NJ: CV Mosby, 1984;338-59.
19. Westgard J.O., Carey R.N., Wold S. Criteria for judging precision and accuracy in method development and evaluation. Clin Chem. 20:1974;825-833.
20. NCCLS. Tentative guideline EP5-T. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, Vol. 4(8), June 1984.
21. Myers GL, Cooper GR, Henderson LO, Hassemer DJ, Kimberley MM. Standardization of lipid and lipoprotein measurements. In: Rifai N, Warnick GR, Eds. Laboratory measurement of lipids, lipoproteins and apolipoproteins. Washington, DC: AACC Press, 1994;177-205.
22. Warnick G.R., Wood P.D. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol executive summary . Clin Chem. 41:1995;1427-1433.